CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Clover Health Investments, Corp. /De quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2020 to Q4 2024.
  • Clover Health Investments, Corp. /De Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2024 was $2.27M, a 38.8% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $2.27M +$635K +38.8% Dec 31, 2024 10-K 2025-03-03
Q4 2023 $1.64M -$1.18M -41.8% Dec 31, 2023 10-K 2025-03-03
Q4 2022 $2.81M +$1.65M +141% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $1.17M -$538K -31.6% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $1.7M Dec 31, 2020 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.